Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 9Not yet recruiting 9Completed 8Unknown 7Active not recruiting 4Terminated 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Breast 1

Conditions

Neoplasms 2Pain 1Neuropathy, Painful 1Neuralgia 1Breast Neoplasms 1Agnosia 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Electroacupuncture × Clear all
NCT02754752 2026-04-15

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
111 enrolled
Breast

Breast Neoplasms

NCT06340906 2026-02-13

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

University of California, Irvine

Phase NA Active not recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT04917796 2026-01-30

ACT

Dana-Farber Cancer Institute

Phase NA Active not recruiting
255 enrolled

Neuropathy, Painful, Agnosia, Neuralgia, Pain

NCT05283577 2026-01-23

EAST

University of California, Irvine

Phase NA Active not recruiting
70 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡